Karayiannis P, O'Rourke S, Watts R, Waters J, Hill V, Carman W F, Thomas H C
Department of Medicine, St. Mary's Hospital Medical School, Imperial College of Science, Technology and Medicine, London, United Kingdom.
Clin Diagn Lab Immunol. 1995 Nov;2(6):708-11. doi: 10.1128/cdli.2.6.708-711.1995.
We have generated a number of recombinant vaccinia viruses which expressed the hepatitis A virus (HAV) structural polypeptides VP1, VP2, VP3, and VP4, either alone or in combination. The relevant sequences encoding these polypeptides were amplified from cloned cDNA by PCR and then cloned into the insertion vector pGS62. The presence of the HAV structural polypeptide-encoding sequences in the recombinant viruses was confirmed by Southern blot analysis, whilst their transcription and translation were demonstrated by Northern (RNA) blot analysis and immunodetection, respectively. Immunoprecipitation studies using these constructs have detected the presence of an anti-VP0 response in human convalescent sera following HAV infection. The significance of this finding and the usefulness of these constructs in studying cell-mediated immunity during recovery from HAV infection are discussed.
我们已经构建了多种重组痘苗病毒,这些病毒单独或组合表达甲型肝炎病毒(HAV)的结构多肽VP1、VP2、VP3和VP4。通过PCR从克隆的cDNA中扩增出编码这些多肽的相关序列,然后克隆到插入载体pGS62中。通过Southern印迹分析证实重组病毒中存在HAV结构多肽编码序列,同时分别通过Northern(RNA)印迹分析和免疫检测证明其转录和翻译。使用这些构建体进行的免疫沉淀研究检测到甲型肝炎病毒感染后人类恢复期血清中存在抗VP0反应。本文讨论了这一发现的意义以及这些构建体在研究甲型肝炎病毒感染恢复过程中细胞介导免疫方面的用途。